Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731171 · ClinicalTrials.gov registry record · NA
Probiotics to Prevent Relapse After Hospitalization for Mania
A NA study, sponsored by Sheppard Pratt Health System.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01731171 is a NA study that has completed, run by Sheppard Pratt Health System. The registered enrollment target is 66 participants.
The verdict
NCT01731171, a NA study, has completed, sponsored by Sheppard Pratt Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking a probiotic supplement versus a placebo will lower rates of relapse and improve the clinical course among participants who have been hospitalized for mania. Relapse and clinical course are measured by time to re-hospitalizations, new mood episodes, and changes in mood-related symptoms.
Interventions
- DIETARY_SUPPLEMENT Probiotic Supplement
- DIETARY_SUPPLEMENT Inert Compound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01731171
The ClinicalTrials.gov registry entry for NCT01731171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sheppard Pratt Health System, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Probiotic Supplement is the first listed.
NCT01731171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01731171 about?
NCT01731171 is a clinical study titled "Probiotics to Prevent Relapse After Hospitalization for Mania". The purpose of this study is to determine if taking a probiotic supplement versus a placebo will lower rates of relapse and improve the clinical course among participants who have been hospitalized for mania. Relapse and clinical course are measured by time to re-hospitalizations, new mood episodes,...
What is the current status of trial NCT01731171?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2012-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01731171?
The interventions under investigation include: Probiotic Supplement (DIETARY_SUPPLEMENT), Inert Compound (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01731171?
This trial is sponsored by Sheppard Pratt Health System, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.